Fina Biosolutions
Rockville, US · Maryland LLC
Find your way into Fina Biosolutions
Sign up to see every warm intro you have to Fina Biosolutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fina Biosolutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.
Founders & leadership
AL
Andrew LeesCEO and Chief Scientific Officer
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2024
▶$3MraisedNov 2024 · 1 investors · OtherRule 506(b)
▶$3MraisedNov 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew LeesExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Nov 2024
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
RscThe Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications. It sets standards for chemical scientists, promotes open access to scientific knowledge, and advocates for chemistry's role in addressing societal challenges including healthcare, environmental protection, and clean energy.
FiveableFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.
Companies working in the same space as Fina Biosolutions.
Frequently asked questions
- What does Fina Biosolutions do?
- Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.
- How much funding has Fina Biosolutions raised?
- Fina Biosolutions has disclosed $3M raised across 1 round.
- Where is Fina Biosolutions headquartered?
- Fina Biosolutions is headquartered in Rockville, US.

